CA
Tema Oncology ETF (CANC)
NASDAQ·Financial Services·Asset Management
$42.54
+1.87%
Mkt Cap $117.66M
Analyst Ratings
No recent rating data.
Price Target (28 analysts)
$211.60
Range $143.52 – $248.40
Implied Upside
+397.5%
Consensus $211.60 vs current $42.54